Skip to main content

Table 4 Distribution RBC indices among anemic adult patients taking AZT based HAART treatment at University of Gondar ART clinic from January 2016 to February 2018

From: Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study

Variable

Category

Proportions n (%)

RBC Indices

Baseline N = 160

6 month N = 141

12 month N = 114

18 month N= 128

24 month N = 130

30 month N = 125

MCV

Microcytic: < 80 fl

14 (8.5%)

13 (9.2%)

10 (8.8%)

11 (8.6%)

11 (8.5%)

6 (4.8%)

Normocytic: 80-100 fl

36 (22.5%)

34 (24.1%)

21 (18.4%)

14 (10.9%)

10 (7.7%)

7 (5.6%)

Macrocytic: > 100 fl

110 (68.75%)

94 (66.7%)

83 (72.8%)

103 (80.5%)

109 (83.8%)

112 (89.6%)

MCH

Hypochromic: < 27 pg

29 (18.1%)

16 (11.3%)

13 (11.4%)

13 (10.2%)

12 (9.2%)

7 (5.6%)

Normochromic: 27-32 pg

38 (23.8%)

16 (11.3%)

16 (14.0%)

11 (8.6%)

8 (6.2%)

7 (5.6%)

Polychromic: > 32 pg

93 (58.1%)

109(77.3%)

85 (74.6%)

104 (81.2%)

110 (84.6%)

111 (88.8%)

MCHC

Hypochromic: < 32 g/dl

73 (45.6%)

40 (28.4%)

34 (29.8%)

26 (20.3%)

39 (30.0%)

23 (18.4%)

Normochromic:32-36 g/dl

76 (47.5%)

89 (63.1%)

62 (54.4%)

78 60.9%)

74 (56.9%)

83 (66.4%)

Polychromic: > 36 g/dl

11 (6.9%)

12 (8.5%)

18 (15.8%)

24 (18.8%)

17 (13.1%)

19 (15.2%)

RDW

Low: < 11.5%

43 (50.6%)

26 (18.4%)

19 (16.7%)

23 (18.0%)

23 (17.7%)

24 (19.2%)

Normal: 11.5–14.5%

100 (47.6%)

105(74.5%)

80 (70.2%)

86 (67.2%)

96 (73.8%)

80 (64.0%)

High: > 14.5%

17 (68.0%)

10 (7.1%)

15 (13.2%)

19 (14.8%)

11 (8.5%)

21 (16.8%)

Severity of Anemia

Mild: 11–11.9 g/dl

95 (29.7%)

95 (29.7%)

85 (26.6%)

87 (27.2%)

93 (29.1%)

81 (25.3%)

Moderate: 8–10.9 g/dl

61 (19.1%)

44 (13.8%)

24 (7.5%)

40 (12.5%)

34 (10.6%)

42 (13.1%)

Severe: < 8 g/dl

4 (1.3%)

2 (0.6%)

5 (1.6%)

1 (0.3)

3 (0.9)

2 (0.6%)